Search results
Results from the WOW.Com Content Network
Lobular carcinoma in situ (LCIS) is an incidental microscopic finding with characteristic cellular morphology and multifocal tissue patterns. The condition is a laboratory diagnosis and refers to unusual cells in the lobules of the breast . [ 1 ]
M8522/2 Intraductal carcinoma and lobular carcinoma in situ (C50._) M8522/3 Infiltrating duct and lobular carcinoma (C50._) Lobular and ductal carcinoma;
Abbreviation Meaning L: leukocytes lumbar vertebrae (L1 to L5) L&D: labor and delivery: LA: left atrium lymphadenopathy local anesthetic: LAAM: L-alpha-acetylmethadol: Lab: laboratory (in health care, usually referring to clinical laboratory) LABA: long-acting beta agonist: LABBB: left anterior bundle branch block: Lac: laceration lactate: LAD
Stage 0 which is in situ disease or Paget's disease of the nipple. Stage 0 is a pre-cancerous or marker condition, either ductal carcinoma in situ (DCIS) or lobular carcinoma in situ (LCIS). Stages 1–3 are within the breast or regional lymph nodes. Stage 4 is a metastatic cancer. Metastatic breast cancer has a less favorable prognosis ...
This is an accepted version of this page This is the latest accepted revision, reviewed on 16 February 2025. Cancer that originates in mammary glands Medical condition Breast cancer An illustration of breast cancer Specialty Surgical oncology Symptoms A lump in a breast, a change in breast shape, dimpling of the skin, fluid from the nipple, a newly inverted nipple, a red scaly patch of skin on ...
It is the official journal of the United States and Canadian Academy of Pathology. The journal is published monthly, with one supplemental issue per year. According to the Journal Citation Reports, Laboratory Investigation has a 2022 impact factor of 5.0, ranking it 14th out of 76 in the category Pathology. [1]
This tissue is sent for pathology testing to assign a histologic classification that is more definitive than a Pap smear result (which is a cytologic finding). HSIL generally corresponds to the histological classification of CIN 2 or 3. [citation needed] HSIL treatment involves the removal or destruction of the affected cells, usually by LEEP.
Carcinoma in situ (CIS) is a group of abnormal cells. [ 1 ] [ 2 ] While they are a form of neoplasm , [ 3 ] there is disagreement over whether CIS should be classified as cancer . This controversy also depends on the exact CIS in question (e.g., cervical, skin, breast).